The Pharmacogenomics Journal Contents: Volume 22 Number 3

In this Issue: Review Article Article

The Pharmacogenomics Journal Contents: Volume 22 Issue 3

Review Article

A systematic review on the cost effectiveness of pharmacogenomics in developing countries: implementation challenges Asif Sukri, Mohd Zaki Salleh, Collen Masimirembwa & Lay Kek Teh Review Article | 22 March 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00272-w

Article

UGT1A1 genetic variants are associated with increases in bilirubin levels in rheumatoid arthritis patients treated with sarilumab Nan Lin, Amy Damask, Anita Boyapati, Jennifer D. Hamilton, Sara Hamon et al. Article | 11 February 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00269-5

Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder Katja Häkkinen, Johanna I. Kiiski, Markku Lähteenvuo, Tuomas Jukuri, Kimmo Suokas et al. Article | 23 February 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00270-y

Whole-genome sequencing analysis of clozapine-induced myocarditis Ankita Narang, Paul Lacaze, Kathlyn J. Ronaldson, John J. McNeil, Mahesh Jayaram et al. Article | 23 April 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00271-x

Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approach Luis Ramudo-Cela, Sara Santana-Martínez, Maite García-Ramos, Mariano Bergamino, Diego García-Giustiniani et al. Article | 31 March 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00274-8

Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis Shangqing Jiang, Patrick C. Mathias, Nathaniel Hendrix, Brian H. Shirts, Peter Tarczy-Hornoch et al. Article | 01 April 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00275-7

Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data Zachary T. Rivers, Helen M. Parsons, Pamala A. Jacobson, Karen M. Kuntz, Joel F. Farley et al. Article | 31 March 2022 The Pharmacogenomics Journal 22 | doi:10.1038/s41397-022-00276-6

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by The Pharmacogenomics Journal.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.